Numerical analysis
Research conducted by Changrui Xing and colleagues at the Nanjing University of Finance and Economics has led to the development of a novel method for detecting phosphoproteins using lateral flow immunoassays. The new method allows for the detection of bovine milk adulteration in goat and camel milk, achieving linear ranges
Amino acids
Patent Title: Antibody-conjugates for targeting of tumours expressing PTK7, inventor Lianne Lelieveldt, was published online on October 14, 2025, with patent number 12440573. The patent is owned by Synaffix B. V. The invention describes novel antibody-conjugates for targeting tumors expressing PTK7, which has been linked to various cancers including colon,
Antibiotics
Researchers at Fujian Normal University have made a groundbreaking discovery in the fight against Vibrio vulnificus infections. By administering IgY antibodies to zebrafish, the team found that the treatment not only significantly enhanced survival rates but also modulated the gut microbiota in a favorable way. The study, funded by the
Stocks
Abpro Holdings, a biotechnology company advancing next-generation antibody therapies, has achieved an estimated ~60% reduction in operating costs through a focused cost optimization plan. The company's DiversImmune (R) platform is positioned to unlock additional pipeline value, and a reverse stock split has been implemented to support Nasdaq compliance
Antibodies
A new study presented fresh data on the progression of coronary artery disease (CAD), a condition affecting millions worldwide. Researchers from the Department of Cardiology in Santander, Spain, conducted a retrospective, single-center, case-control study to determine whether antiphospholipid (aPL) and antinuclear antibodies (ANA) predict CAD progression. The study included 180
AIDS vaccines
Researchers from Amsterdam University Medical Center have published a study in PLOS Pathogens detailing the development of a vaccine that induces both neutralizing antibodies and antibody-mediated effector functions against HIV-1. This breakthrough could potentially curb the ongoing global HIV-1 epidemic. The vaccine, ConM SOSIP.v7, was tested in preclinical and
Antibodies
A new study presented fresh data on the progression of coronary artery disease (CAD), a condition affecting millions worldwide. Researchers from the Department of Cardiology in Santander, Spain, conducted a retrospective, single-center, case-control study to determine whether antiphospholipid (aPL) and antinuclear antibodies (ANA) predict CAD progression. The study included 180
AIDS vaccines
Researchers from Amsterdam University Medical Center have published a study in PLOS Pathogens detailing the development of a vaccine that induces both neutralizing antibodies and antibody-mediated effector functions against HIV-1. This breakthrough could potentially curb the ongoing global HIV-1 epidemic. The vaccine, ConM SOSIP.v7, was tested in preclinical and
Antibodies
Research has revealed that SARS-CoV-2 continues to evolve, causing waves of infections, and it is crucial to understand the characteristics of the virus responsible for its growth advantages. According to a recent study published in Cell Reports, the SARS-CoV-2 Omicron JN.1 subvariants KP.3.1.1 and XEC were
Antibodies
Residents in the Lower Mainland region of British Columbia, Canada, have shown a high level of immunity to measles, with 90% of people having detectable antibodies against the disease. This high coverage is attributed to the strong vaccine uptake in the region, particularly among children, with 92% to 94% of
Antibodies
Researchers have made a significant discovery in the treatment of psoriasis, a chronic autoimmune disease that affects millions of people worldwide. The study, published in the International Journal of Molecular Sciences, sheds light on the phenomenon of anti-drug antibodies (ADAs) in psoriasis patients. According to the research, biological drugs, which
Antibodies
Researchers at the University of Paris have made significant progress in diagnosing past COVID-19 infections using a combination of T-SPOT assays and antibody tests. The study aimed to evaluate the efficacy of T-SPOT assays in detecting cell-mediated immune responses against SARS-CoV-2. The findings suggest that integrating cellular and humoral immunity
